Ledger.Open graph →
SEC Form D · filed July 29, 2022

RevOpsis Therapeutics, Inc

Offering
$521K
Sold
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Springfield, IL
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Ram P. Palanki · Springfield, ILExec · DirectorJeff P. Olson · Springfield, ILDirectorRamanath Bhandari · Springfield, ILExec · Director · PromoterSteven Decillis · NEW YORK, NYExec · DirectorAnne Labelle · Vancouver, British Columbia, CanadaDirectorSabrina Vallano · London, United KingdomExec · Director · PromoterCarly Brantz · SAN FRANCISCO, CAExec · Director · PromoterScott P. Lennon · Camana Bay, Grand Cayman, Cayman IslandsDirectorClaire P. Musgrave · Camana Bay, Grand Cayman, Cayman IslandsExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗